+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?



Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?



International Journal of Radiation Oncology, Biology, Physics 63(3): 745-752



This study set out to determine the impact of a positive circumferential resection margin (CRM) (R1-R2) and pathologic downstaging on local recurrence and survival in patients with borderline resectable or unresectable rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy (CRT). A total of 150 patients with locally advanced rectal cancer were treated with long-course neoadjuvant CRT using low-dose folinic acid and 5-fluorouracil. CRT was followed 6-12 weeks later by surgical excision. The CRM rate and incidence, site, and pattern of local and systemic recurrences were recorded. The median follow-up was 25 months. The overall median survival was 37 months, with a 5-year overall survival rate of 34%. Of the 150 patients, 122 underwent curative resection; 12% had a complete pathologic response, and downstaging to pT1-T2 occurred in an additional 16%. A negative CRM (R0) was achieved in 65% overall (98 of 150). Local recurrence occurred in 10% of those with R0 resection and 62% of those with R1-R2 resections. Distant metastases occurred in 29% of those with R0 resections and 75% of those with R1-R2 resections. The 3-year disease-free and 3-year overall survival rate was 9% and 25% and 52% and 64%, respectively, for patients with and without a histologically positive CRM. After 5-fluorouracil-based CRT, a positive CRM predicted for a high risk of subsequent local recurrence and a 3-year disease-free survival rate of only 9%. For this reason, the CRM should be considered a major prognostic factor and should be validated in future trials as an early alternative clinical endpoint.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011827525

Download citation: RISBibTeXText

PMID: 16199310

DOI: 10.1016/j.ijrobp.2005.03.003


Related references

Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?. Yearbook of Surgery 2007: 315-318, 2007

What is the best way to predict disease-free survival after preoperative radiochemotherapy for rectal cancer patients: tumor regression grading, nodal status, or circumferential resection margin invasion?. Journal of Clinical Oncology 24(8): 1319; Author Reply 1320-1, 2006

Mandard tumour regression grade, perineural invasion, circumferential resection margin and post-chemoradiation nodal status strongly predict outcome in locally advanced rectal cancer treated with preoperative chemoradiotherapy. Clinical Oncology ) 26(4): 197-202, 2015

Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study. Journal of Clinical Oncology 32(1): 34-43, 2014

Prognostic impact of circumferential resection margin in rectal cancer treated with preoperative chemoradiotherapy. Annals of Surgical Oncology 21(4): 1345-1351, 2014

Prognostic significance of circumferential margin involvement after long-term preoperative chemoradiotherapy and surgery for rectal cancer. Annals of Surgical Oncology 11(2 Supplement): S111-0, 2004

Magnetic resonance imaging predicts circumferential resection margin status in patients receiving preoperative chemoradiotherapy for rectal cancer. Colorectal Disease 9(2): 188-188, 2007

Magnetic resonance imaging predicts circumferential resection margin status in patients receiving preoperative chemoradiotherapy for rectal cancer. Colorectal Disease 8(9): 816-816, 2006

Clinical implication of negative conversion of predicted circumferential resection margin status after preoperative chemoradiotherapy for locally advanced rectal cancer. European Journal of Radiology 83(2): 245-249, 2014

Variations in pelvic dimensions do not predict the risk of circumferential resection margin (CRM) involvement in rectal cancer. World Journal of Surgery 31(6): 1313-1320, 2007

The clinical significance of the circumferential resection margin following preoperative pelvic chemo-radiotherapy in rectal cancer: why we need a common language. Colorectal Disease 8(9): 800-807, 2006

Can CT replace MRI in preoperative assessment of the circumferential resection margin in rectal cancer?. Diseases of the Colon and Rectum 53(3): 308-314, 2010

Preoperative assessment of the circumferential margin in rectal cancer is more informative in treatment planning than the T stage. Techniques in Coloproctology 10(3): 171-176, 2006

Circumferential resection margin positivity after preoperative chemoradiotherapy based on magnetic resonance imaging for locally advanced rectal cancer: implication of boost radiotherapy to the involved mesorectal fascia. Japanese Journal of Clinical Oncology 46(4): 316-322, 2016

Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer. Journal of the National Cancer Institute 109(12), 2017